SuperSonic Imagine to Showcase Enhanced Breast Imaging Package at Two Leading Breast Health Meetings - Seite 2

"We always look forward to meeting with clinicians in the breast health space, whose imaging needs SSI has worked tirelessly to meet. We know how important it is to visualize breast tissue as clearly as possible, and we continually improve that potentially life-saving capability," said Jacques Souquet, Founder and Chief Innovation Officer of SuperSonic Imagine. "We look forward to sharing the newly enhanced features of the Aixplorer, including the exclusive TriVu real-time simultaneous mode, which may prove valuable to breast evaluation as it combines anatomical and functional imaging in one test."

Attendees are invited to join SSI in symposia and on the exhibit floor:

The 27th Annual Interdisciplinary Breast Center Conference
https://www2.breastcare.org/welcome-to-the-annual-national-interdisciplinary-breast-center-conference/
March 11 - 15 in Las Vegas
Paris Las Vegas Hotel Rivoli Hall, booth #400

The 2017 SBI/ACR Breast Imaging Symposium
https://www.eventscribe.com/2017/SBI-ACR/
April 6 - 9 in Los Angeles
Westin Bonaventure Hotel and Suites, Pasadena Hall, Booth 325

About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. In addition to providing exceptional image quality, this unique technology is the foundation of several innovations which have changed the paradigm of ultrasound imaging: ShearWave™ Elastography (SWE™), UltraFast™ Doppler, Angio PL.U.S - Planewave UltraSensitive™ Imaging and more recently TriVu.

ShearWave Elastography allows physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This criteria has become an important parameter in diagnosing potentially malignant tissue or other diseased tissue. As of today, over 300 peer-reviewed publications have demonstrated the value of SWE for the clinical management of patients with a wide range of diseases.

UltraFast Doppler combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam, providing physicians with exam results simultaneously and helping to increase patient throughput. The latest innovation, Angio PL.U.S, provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging.

SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in key global markets. SuperSonic Imagine is a listed company since April 2014 on the Euronext, symbol SSI.

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

Contact information:

SuperSonic Imagine
Marketing & Communication
Emmanuelle Vella
Email Contact
[phone]

NewCap
Investor Relations - EU
Pierre Laurent / Florent Alba
Email Contact
[phone]

Pascale Communication
Media Relations - US
Amy Phillips
Email Contact
[phone]